Home › Blog › Blueberries or Statins to Reduce Heart Attack Risk? Your Call…

An important paper came out this week on how eating blueberries reduces heart risk. Yes, you heard that right, blueberries. In fact it’s fruits that contain Anthocyanin, which include lots of berries, cherries, and grapes. I just read the full paper and produced the chart you see above. First, a caution. The blueberry data is from looking at the Framingham research data so it’s not information collected by testing blueberries in a population and looking at the number of heart attacks, it was collected after the fact by meticulously monitoring a large population of women. The data above for statins was collected by giving statin cholesterol drugs versus placebo and monitoring heart attacks.

From the table above, it’s clear that this likely isn’t even a fair fight. Eating blueberries in research by the same authors have also been associated with reduced type 2 diabetes risk and reduced blood pressure (less hypertension). In reviewing the chart above, you might be wondering why I didn’t quote the number thrown around by Pfizer for how much the cholesterol miracle cure Lipitor reduces heart attack risk (36%). This is because it’s not a 36% reduction in heart attack risk, but “relative risk”. You get to 36% only after a little creative math quoting that the difference between the percentage of heart attacks in the Lipitor versus the placebo group (2% versus 3%). Businessweek had an excellent article exposing cholesterol drugs in 2008.  I’ve already blogged extensively about the side effects of statins, which include fatigue, memory loss, muscle damage, cartilage loss, nerve cell damage, and chronic pain. The upshot? Yikes! Eat your blueberries!

Learn More About Regenexx^® Procedures

Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.

Your Email *

Include the weekly newsletter. It's free and you can unsubscribe at any time.

Submit

We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile